Display options
Cite
Kulik A, Le May M, Wells GA, et al. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]. Curr Control Trials Cardiovasc Med. 2005;6:15doi: 10.1186/1468-6708-6-15.
Kulik, A., Le May, M., Wells, G. A., Mesana, T. G., & Ruel, M. (2005). The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]. Current controlled trials in cardiovascular medicine, 615. https://doi.org/10.1186/1468-6708-6-15
Kulik, Alexander, et al. "The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]." Current controlled trials in cardiovascular medicine vol. 6 (2005): 15. doi: https://doi.org/10.1186/1468-6708-6-15
Kulik A, Le May M, Wells GA, Mesana TG, Ruel M. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]. Curr Control Trials Cardiovasc Med. 2005 Oct 11;6:15. doi: 10.1186/1468-6708-6-15. PMID: 16219100; PMCID: PMC1282584.
Copy Download .nbib Format: NLM
Share it on

Curr Control Trials Cardiovasc Med. 2005 Oct 11;6:15. doi: 10.1186/1468-6708-6-15.

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423].

Current controlled trials in cardiovascular medicine

Alexander Kulik, Michel Le May, George A Wells, Thierry G Mesana, Marc Ruel

Affiliations

  1. Division of Cardiac Surgery, University of Ottawa Heart Institute, and Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada. [email protected]

PMID: 16219100 PMCID: PMC1282584 DOI: 10.1186/1468-6708-6-15

Abstract

BACKGROUND: Saphenous vein graft disease remains a major limitation of coronary artery bypass graft surgery. The process of saphenous vein intimal hyperplasia begins just days after surgical revascularization, setting the stage for graft atherosclerotic disease and its sequalae. Clopidogrel improves outcomes in patients with atherosclerotic disease, and is effective at reducing intimal hyperplasia in animal models of thrombosis. Therefore, the goal of this study will be to evaluate the efficacy of clopidogrel and aspirin therapy versus aspirin alone in the prevention of saphenous vein graft intimal hyperplasia following coronary artery bypass surgery.

METHODS: Patients undergoing multi-vessel coronary artery bypass grafting and in whom at least two saphenous vein grafts will be used are eligible for the study. Patients will be randomized to receive daily clopidogrel 75 mg or placebo, in addition to daily aspirin 162 mg, for a one year duration starting on the day of surgery (as soon as postoperative bleeding has been excluded). At the end of one year, all patients will undergo coronary angiography and intravascular ultrasound assessment of one saphenous vein graft as selected by randomization. The trial will be powered to test the hypothesis that clopidogrel and aspirin will reduce vein graft intimal hyperplasia by 20% compared to aspirin alone at one year following bypass surgery.

DISCUSSION: This trial is the first prospective human study that will address the question of whether clopidogrel therapy improves outcomes and reduces saphenous vein graft intimal hyperplasia following cardiac surgery. Should the combination of clopidogrel and aspirin reduce the process of vein graft intimal hyperplasia, the results of this study will help redefine modern antiplatelet management of coronary artery bypass patients.

References

  1. J Clin Invest. 1992 Feb;89(2):507-11 - PubMed
  2. Circulation. 2004 Sep 7;110(10):1202-8 - PubMed
  3. Am J Cardiol. 2004 Sep 1;94(5):623-5 - PubMed
  4. Circulation. 2004 Oct 5;110(14):e340-437 - PubMed
  5. Arch Intern Med. 2004 Oct 25;164(19):2106-10 - PubMed
  6. N Engl J Med. 2005 May 26;352(21):2174-83 - PubMed
  7. J Am Coll Cardiol. 1991 Apr;17(5):1081-3 - PubMed
  8. Circulation. 1989 Nov;80(5):1190-7 - PubMed
  9. Proc Natl Acad Sci U S A. 1989 Nov;86(21):8412-6 - PubMed
  10. Circulation. 1988 Jun;77(6):1324-32 - PubMed
  11. JAMA. 1987 Jun 19;257(23):3233-40 - PubMed
  12. N Engl J Med. 1986 Feb 20;314(8):488-500 - PubMed
  13. N Engl J Med. 1985 Apr 4;312(14):932-6 - PubMed
  14. N Engl J Med. 1984 Nov 22;311(21):1329-32 - PubMed
  15. Circulation. 1995 Nov 1;92(9 Suppl):II31-6 - PubMed
  16. Curr Opin Cardiol. 1994 Nov;9(6):641-9 - PubMed
  17. Can J Cardiol. 1995 Mar;11(3):221-7 - PubMed
  18. Stroke. 1994 Dec;25(12):2331-6 - PubMed
  19. Circulation. 1994 Dec;90(6):3125-33 - PubMed
  20. Circulation. 1994 Mar;89(3):1138-43 - PubMed
  21. Am J Cardiol. 1994 Jan 15;73(2):103-12 - PubMed
  22. Arterioscler Thromb. 1993 Aug;13(8):1171-9 - PubMed
  23. J Am Coll Cardiol. 1993 Oct;22(4):1141-54 - PubMed
  24. Lab Invest. 1977 Apr;36(4):452-64 - PubMed
  25. J Am Coll Cardiol. 1996 Sep;28(3):616-26 - PubMed
  26. Ann Thorac Surg. 1996 Sep;62(3):915-22 - PubMed
  27. N Engl J Med. 1996 Oct 3;335(14):1001-9 - PubMed
  28. Lancet. 1996 Nov 16;348(9038):1329-39 - PubMed
  29. Heart. 1996 Oct;76(4):317-20 - PubMed
  30. N Engl J Med. 1997 Jan 16;336(3):153-62 - PubMed
  31. Int J Cardiol. 1997 Jan 31;58(2):119-26 - PubMed
  32. Circulation. 1998 Mar 10;97(9):916-31 - PubMed
  33. Can J Cardiol. 1998 May;14(5):671-7 - PubMed
  34. Thromb Haemost. 1998 Sep;80(3):512-8 - PubMed
  35. Circulation. 1998 Dec 1;98(22):2461-9 - PubMed
  36. Med Clin North Am. 2000 Jan;84(1):163-79, ix - PubMed
  37. Circulation. 2000 Jun 20;101(24):2823-8 - PubMed
  38. Circulation. 2001 Jan 23;103(3):363-8 - PubMed
  39. Nature. 2001 Jan 11;409(6817):202-7 - PubMed
  40. Lancet. 2001 Apr 14;357(9263):1191-4 - PubMed
  41. N Engl J Med. 2001 Aug 16;345(7):494-502 - PubMed
  42. Circulation. 2001 Sep 25;104(13):1577-9 - PubMed
  43. BMJ. 2002 Jan 12;324(7329):71-86 - PubMed
  44. Thromb Res. 2002 Jan 15;105(2):173-5 - PubMed
  45. Am Heart J. 2002 Oct;144(4):589-96 - PubMed
  46. Cardiovasc Pathol. 2002 Sep-Oct;11(5):263-71 - PubMed
  47. J Am Coll Cardiol. 2003 Mar 19;41(6):961-5 - PubMed
  48. Heart Dis. 2003 Mar-Apr;5(2):144-52 - PubMed
  49. Circulation. 2003 Aug 5;108(5):542-7 - PubMed
  50. Cardiovasc Drugs Ther. 2003 Sep-Nov;17(5-6):467-77 - PubMed

Publication Types